AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27306372 — intervention group
Group type: COMPARATOR
Intervention: Food effect on roflumilast
Number of subjects: 36
Study 27306372 — intervention group
Group type: COMPARATOR
Intervention: Gender effect on roflumilast and roflumilast N-oxide
Number of subjects: 36
Study 26474518 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib (150 mg once daily)
Number of subjects: 700
Study 26474518 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab (7.5 mg/kg every 3 weeks)
Number of subjects: 700
Study 23011122 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-belt treadmill walking
Number of subjects: 15
Study 23011122 — intervention group
Group type: COMPARATOR
Intervention: Slow treadmill walking
Number of subjects: 15
Study 23011122 — intervention group
Group type: COMPARATOR
Intervention: Fast treadmill walking
Number of subjects: 15
Study 21609207 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg
Number of subjects: 101
Study 21609207 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 400 mg
Number of subjects: 101
Study 21609207 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 101
Study 21609207 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (active control)
Number of subjects: 101
Study 19332727 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant doxorubicin (75 mg/m(2)) followed by CMF
Number of subjects: 1355
Study 19332727 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant paclitaxel (200 mg/m(2)) plus doxorubicin (60 mg/m(2)), followed by CMF
Number of subjects: 1355
Study 19332727 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (200 mg/m(2)) plus doxorubicin (60 mg/m(2)) followed by CMF followed by surgery
Number of subjects: 1355
Study 16460241 — intervention group
Group type: EXPERIMENTAL
Intervention: Semilunar coronally positioned flap (SCPF)
Number of subjects: 17
Study 16460241 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 17
Study 15288707 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg orally at 2300 h)
Number of subjects: 14
Study 15288707 — intervention group
Group type: COMPARATOR
Intervention: Control group (14 subjects; 11 female, 3 male; mean age 15.7 ± 2.0 years)
Number of subjects: 14
Study 11814087 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing (AAI)
Number of subjects: 74
Study 11814087 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing (VVI)
Number of subjects: 74
Study 9801900 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (batch 1)
Number of subjects: 816
Study 9801900 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (batch 2)
Number of subjects: 816
Study 9801900 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 816
Study 7620271 — intervention group
Group type: EXPERIMENTAL
Intervention: Asahi PAN 06 hollow fibre dialyser
Number of subjects: 7
Study 7620271 — intervention group
Group type: COMPARATOR
Intervention: Hospal AN69HF flat plate dialyser
Number of subjects: 7
Study 2559242 — intervention group
Group type: EXPERIMENTAL
Intervention: Continental breakfast (low fibre, low protein, high fat)
Number of subjects: 32
Study 2559242 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk (low fat, high protein)
Number of subjects: 32
Study 2559242 — intervention group
Group type: EXPERIMENTAL
Intervention: English breakfast (high fibre, high protein)
Number of subjects: 32
Study 2559242 — intervention group
Group type: COMPARATOR
Intervention: Continental breakfast
Number of subjects: 32
Study 2559242 — intervention group
Group type: COMPARATOR
Intervention: Milk
Number of subjects: 32
Study 2559242 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meals in closed-loop experiments
Number of subjects: 32
Study 336078 — intervention group
Group type: COMPARATOR
Intervention: Bellergal (combination of belladonna alkaloids, ergotamine tartrate, and phenobarbitone), administered three times daily
Number of subjects: 0
Study 336078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30885389 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall + EM (32 intervals of 24s)
Number of subjects: 100
Study 30885389 — intervention group
Group type: COMPARATOR
Intervention: Recall only (32 intervals of 24s)
Number of subjects: 100
Study 31585579 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised moderate to vigorous exercise (70 to 78 sessions over 24 weeks, 3 times per week, 60-65 minutes per session)
Number of subjects: 345
Study 31585579 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised moderate to vigorous exercise
Number of subjects: 345
Study 31585579 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 345
Study 28467869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg twice daily)
Number of subjects: 1732
Study 28467869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice daily)
Number of subjects: 1732
Study 28467869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1732
Study 26449871 — intervention group
Group type: EXPERIMENTAL
Intervention: IP-OP suction (10 Fr suction catheter, negative pressure of 100 mmHg)
Number of subjects: 509
Study 26449871 — intervention group
Group type: COMPARATOR
Intervention: No IP-OP suction (control group)
Number of subjects: 509
Study 26449871 — intervention group
Group type: EXPERIMENTAL
Intervention: IP-OP suction
Number of subjects: 509
Study 26449871 — intervention group
Group type: COMPARATOR
Intervention: No IP-OP suction
Number of subjects: 509
Study 24655978 — intervention group
Group type: EXPERIMENTAL
Intervention: EVL plus atorvastatin 20 mg
Number of subjects: 20
Study 24655978 — intervention group
Group type: COMPARATOR
Intervention: EVL
Number of subjects: 20
Study 22979932 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for dry eye (3 weeks duration)
Number of subjects: 65
Study 22979932 — intervention group
Group type: COMPARATOR
Intervention: Artificial tear therapy (control group, 3 weeks duration)
Number of subjects: 65
Study 22979932 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (1 week after treatment)
Number of subjects: 65
Study 19203163 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 127
Study 19203163 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual for juvenile sexual offenders (TAU-JSO)
Number of subjects: 127
Study 17301733 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (300 ml) with 120 mg fexofenadine
Number of subjects: 12
Study 17301733 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous solution of naringin (1,200 microM) with 120 mg fexofenadine
Number of subjects: 12
Study 17301733 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice with 120 mg fexofenadine
Number of subjects: 12
Study 17301733 — intervention group
Group type: EXPERIMENTAL
Intervention: Particulate fraction of juice with 120 mg fexofenadine
Number of subjects: 12
Study 17301733 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 15333083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine infusion
Number of subjects: 20
Study 11584487 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the Neiguan point (P6)
Number of subjects: 60
Study 11584487 — intervention group
Group type: COMPARATOR
Intervention: Acupressure at a placebo point
Number of subjects: 60
Study 11584487 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study 9855523 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 145
Study 9855523 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 145
Study 9855523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a bolus (375 mg in 120 ml water)
Number of subjects: 9
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a 4-hour infusion (375 mg in 120 ml water)
Number of subjects: 9
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a bolus in the ileum
Number of subjects: 9
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin administered as a 4-hour infusion in the ileum
Number of subjects: 9
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin infused in colonic regions
Number of subjects: 9
Study 7924123 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dose of amoxicillin solution
Number of subjects: 9
Study 31942838 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg grape seed polyphenol extract (GSPE)
Number of subjects: 60
Study 31942838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31469220 — intervention group
Group type: EXPERIMENTAL
Intervention: EQW + Plb
Number of subjects: 678
Study 31469220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapa + Plb
Number of subjects: 678
Study 31469220 — intervention group
Group type: EXPERIMENTAL
Intervention: EQW + Dapa
Number of subjects: 678
Study 31469220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapa
Number of subjects: 678
Study 30488853 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate supervised aerobic training, 3 days per week for 6 months
Number of subjects: 41
Study 30488853 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change in physical activity)
Number of subjects: 41
Study 27521807 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Control
Number of subjects: 311
Study 27521807 — intervention group
Group type: COMPARATOR
Intervention: Therapist-Delivered Platforms (TDP)
Number of subjects: 311
Study 24962353 — intervention group
Group type: EXPERIMENTAL
Intervention: ED-initiated palliative care referral
Number of subjects: 125
Study 24962353 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study 22882753 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sumatriptan tablet with 50 mL of water
Number of subjects: 10
Study 22882753 — intervention group
Group type: COMPARATOR
Intervention: 50 mL of water alone (control)
Number of subjects: 10
Study 20335070 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg for the first day, then 75 mg daily) plus aspirin (75-160 mg daily)
Number of subjects: 100
Study 20335070 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (75-160 mg daily)
Number of subjects: 100
Study 18822200 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 80
Study 18822200 — intervention group
Group type: COMPARATOR
Intervention: Entecavir
Number of subjects: 80
Study 17002742 — intervention group
Group type: EXPERIMENTAL
Intervention: KetacCem (Group A)
Number of subjects: 32
Study 17002742 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia21EX (Group B)
Number of subjects: 32
Study 14576377 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke patients
Number of subjects: 100
Study 14576377 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 100
Study 11291603 — intervention group
Group type: EXPERIMENTAL
Intervention: IDDM patients
Number of subjects: 25
Study 11291603 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 25
Study 11291603 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva tests and deep breathing HR response tests
Number of subjects: 25
Study 8970679 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV/ddC/3TC (n = 15)
Number of subjects: 46
Study 8970679 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV/3TC (n = 15)
Number of subjects: 46
Study 8970679 — intervention group
Group type: COMPARATOR
Intervention: ZDV/ddC (control group; n = 16)
Number of subjects: 46
Study 1344237 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing through a simple face mask with an oxygen inflow of 6L/min (Group II)
Number of subjects: 45
Study 1344237 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing oxygen with a flow rate of 10L/min through a simple face mask (Group III)
Number of subjects: 45
Study 1344237 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air (Group I)
Number of subjects: 45
Study 6199271 — intervention group
Group type: EXPERIMENTAL
Intervention: prajmalin
Number of subjects: 0
Study 6199271 — intervention group
Group type: EXPERIMENTAL
Intervention: propafenone
Number of subjects: 0
Study 6199271 — intervention group
Group type: EXPERIMENTAL
Intervention: disopyramide
Number of subjects: 0
Study 6199271 — intervention group
Group type: EXPERIMENTAL
Intervention: sparteine
Number of subjects: 0
Study 6199271 — intervention group
Group type: EXPERIMENTAL
Intervention: nitroglycerin
Number of subjects: 0
Study 29283916 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal warming (fluid at 42°C)
Number of subjects: 19
Study 29283916 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal cooling (exchanger fluid at 7°C)
Number of subjects: 19
Study 27496921 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii exercise programme
Number of subjects: 80
Study 27496921 — intervention group
Group type: COMPARATOR
Intervention: Gym-based exercise intervention
Number of subjects: 80
Study 25739245 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium elastic nail (TEN)
Number of subjects: 32
Study 25739245 — intervention group
Group type: COMPARATOR
Intervention: Plate-screw fixation (PF)
Number of subjects: 32
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 1763
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure with symptoms
Number of subjects: 1763
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Low walking speed
Number of subjects: 1763
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced mobility (PCA component)
Number of subjects: 1763
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart dysfunction (PCA component)
Number of subjects: 1763
Study 23919320 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional impairment including nocturia (PCA component)
Number of subjects: 1763
Study 20428723 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 1 (E1: 20 minutes)
Number of subjects: 16
Study 20428723 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise 2 (E2: 40 minutes)
Number of subjects: 16
Study 20428723 — intervention group
Group type: COMPARATOR
Intervention: Control (C: 40 minutes)
Number of subjects: 16
Study 19290473 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam 8 mg i.v. at the end of the operation, followed by 8 mg 12 h after the operation
Number of subjects: 160
Study 19290473 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 1 mg/kg at the end of the operation and every 6 h up to 24 h postoperatively
Number of subjects: 160
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-weighted inversion recovery (IR)
Number of subjects: 31
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-weighted spin-echo (SE)
Number of subjects: 31
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-weighted gradient echo (GE)
Number of subjects: 31
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced gradient echo (CE-GE)
Number of subjects: 31
Study 15838759 — intervention group
Group type: COMPARATOR
Intervention: Contrast-enhanced spin-echo (CE-SE)
Number of subjects: 31
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: CNR of basal ganglia for IR
Number of subjects: 31
Study 15838759 — intervention group
Group type: EXPERIMENTAL
Intervention: CNR of cortex for IR
Number of subjects: 31
Study 12610744 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 2.5 microg/ml
Number of subjects: 10
Study 12610744 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 10 microg/ml
Number of subjects: 10
Study 12610744 — intervention group
Group type: COMPARATOR
Intervention: Reference compound antipyrine (100 microg/ml)
Number of subjects: 10
Study 12610744 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vein and cord blood samples from epileptic mothers
Number of subjects: 10
Study 10582898 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral trovafloxacin (200 mg)
Number of subjects: 12
Study 10582898 — intervention group
Group type: COMPARATOR
Intervention: Intravenous alatrofloxacin
Number of subjects: 12
Study 8692619 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg per day for 12 days, tapered progressively)
Number of subjects: 70
Study 8692619 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 70
Study 8692619 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 70
Study 1879386 — intervention group
Group type: EXPERIMENTAL
Intervention: Seventeen meals daily
Number of subjects: 7
Study 1879386 — intervention group
Group type: COMPARATOR
Intervention: Three meals daily
Number of subjects: 7
Study 6603716 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin (5 mg/kg body weight, intramuscular injection)
Number of subjects: 0
Study 6603716 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin combined with beta-Lactam antibiotics
Number of subjects: 0
Study 6603716 — intervention group
Group type: COMPARATOR
Intervention: Newer aminoglycosides
Number of subjects: 0
Study 30905227 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term antenatal indomethacin treatment (LIT)
Number of subjects: 166
Study 30905227 — intervention group
Group type: COMPARATOR
Intervention: Control (unexposed neonates)
Number of subjects: 166
Study 29767754 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 900
Study 29767754 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 900
Study 29767754 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropins
Number of subjects: 900
Study 29767754 — intervention group
Group type: EXPERIMENTAL
Intervention: OS‐IUI cycles (all treatments)
Number of subjects: 900
Study 27527730 — intervention group
Group type: EXPERIMENTAL
Intervention: face-to-face contact + educational lecture
Number of subjects: 102
Study 27527730 — intervention group
Group type: EXPERIMENTAL
Intervention: video-based contact + educational lecture
Number of subjects: 102
Study 23231528 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized management program group
Number of subjects: 0
Study 23231528 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22608476 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK eyes with severe sensation loss
Number of subjects: 31
Study 22608476 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK eyes
Number of subjects: 31
Study 22608476 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK eyes with normal sensation
Number of subjects: 31
Study 22608476 — intervention group
Group type: EXPERIMENTAL
Intervention: HSK eyes with mild sensation loss
Number of subjects: 31
Study 22608476 — intervention group
Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 31
Study 20535658 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 day/wk interval training at 110-120% of peak workload
Number of subjects: 20
Study 20535658 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 days/wk interval training at 110-120% of peak workload
Number of subjects: 20
Study 18267054 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 19
Study 18267054 — intervention group
Group type: COMPARATOR
Intervention: Travoprost 0.004%
Number of subjects: 19
Study 17316487 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐Zagreb, L‐Zagreb, and Wistar RA 27/3 (Tresivac)
Number of subjects: 692
Study 17316487 — intervention group
Group type: EXPERIMENTAL
Intervention: Moraten, J‐Lynn, and Wistar RA 27/3 (M‐M‐R II)
Number of subjects: 692
Study 17316487 — intervention group
Group type: EXPERIMENTAL
Intervention: Schwarz, Urabe AM‐9, and Wistar RA 27/3 (Trimovax)
Number of subjects: 692
Study 17316487 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (before vaccination)
Number of subjects: 692
Study 12611835 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/day
Number of subjects: 276
Study 12611835 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 276
Study 12611835 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 6 mg/day
Number of subjects: 276
Study 12611835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 11098967 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted spontaneous breathing
Number of subjects: 0
Study 11098967 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation
Number of subjects: 0
Study 11098967 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic positive airway pressure
Number of subjects: 0
Study 9343646 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg intra-articular morphine
Number of subjects: 0
Study 9343646 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg intra-articular morphine
Number of subjects: 0
Study 9343646 — intervention group
Group type: COMPARATOR
Intervention: 5 mg intravenous morphine
Number of subjects: 0
Study 9343646 — intervention group
Group type: COMPARATOR
Intervention: 100 mg bupivacaine
Number of subjects: 0
Study 9343646 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study 8338088 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (Fleet Phospho‐Soda)
Number of subjects: 113
Study 8338088 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon‐flavored castor oil (Purge)
Number of subjects: 113
Study 8338088 — intervention group
Group type: COMPARATOR
Intervention: Standard polyethylene glycol‐based lavage solution (GoLYTELY)
Number of subjects: 113
Study 3505526 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 5 mg/2 ml
Number of subjects: 0
Study 3505526 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 10 mg/4 ml
Number of subjects: 0
Study 3505526 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 0
Study 3505526 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (both dosages)
Number of subjects: 0